A Pretreatment Psa Level Of 7 To 10 Ng/Ml Is An Independent Predictor Of Adverse Biochemical Disease Free Survival Among Low Risk Prostate Cancer Patients Treated With I-125 Brachytherapy

International Journal of Radiation Oncology Biology Physics(2008)

引用 0|浏览7
暂无评分
关键词
risk prostate cancer,prostate cancer patients,pretreatment psa level,prostate cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要